These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6484840)

  • 1. [Effect of hemodialysis and hemosorption on blood serum level of medium-molecular components in patients with chronic renal failure].
    Kozlov VV; Riabov SI; Dorofeeva TB; von Appen K; Spiridonov VN
    Ter Arkh; 1984; 56(7):77-81. PubMed ID: 6484840
    [No Abstract]   [Full Text] [Related]  

  • 2. [The evaluation of the efficacy of efferent therapy in patients with acute and chronic kidney failure by the spectrum of blood middle-molecule fractions].
    Kon'kova TA; Chudnovskaia MV; Golovanov SA
    Urol Nefrol (Mosk); 1994; (4):35-7. PubMed ID: 7985299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood viscosity and the erythrocyte charge in patients with chronic kidney failure and suppurative intoxication and during the correction of these conditions by hemosorption and hemodialysis].
    Samoĭlov MV; Zakharchenko VN; Larionov SM; Naumov AG; Danilkov AP; Zakharova VD; Ivleva AI; Kudriavtsev IuV; Surikova TP
    Urol Nefrol (Mosk); 1993; (4):34-7. PubMed ID: 8310565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies on the effect of hemoperfusion and hemodialysis on the elimination of some uremic toxins.
    Trznadel K; Walasek L; Kidawa Z; Lutz W
    Clin Nephrol; 1978 Dec; 10(6):229-31. PubMed ID: 729215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electromyography in patients in the terminal stages of chronic renal failure treated with regular hemodialysis and hemosorption].
    Ender LA; Lagutina TS; Cherniakov VL; Shcherbakova EO; Shcherbakov VA
    Urol Nefrol (Mosk); 1984; (5):57-62. PubMed ID: 6095507
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of hemosorption and hemodialysis in the treatment of chronic renal failure].
    Riabov SI; Shostka GD; Lukichev BG; Strelko VV; Spiridonov VN
    Ter Arkh; 1981; 53(6):15-21. PubMed ID: 7281026
    [No Abstract]   [Full Text] [Related]  

  • 7. [Function of the blood prekallikrein-kallikrein system of patients with terminal kidney failure as affected by hemosorption].
    Petrun' NM; Baran EIa; Krimkevich EI
    Urol Nefrol (Mosk); 1986; (6):41-4. PubMed ID: 2433828
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodialysis and hemosorption in acute kidney failure].
    Kanus II
    Urol Nefrol (Mosk); 1990; (1):13-6. PubMed ID: 2336750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concentration of medium molecular weight components in serum and ultrafiltrate in patients with chronic renal failure].
    Popławski A
    Pol Tyg Lek; 1991 Oct 7-21; 46(40-42):750-2. PubMed ID: 1669151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A quantitative method of determining middle molecule peptides in the blood serum of patients with chronic renal insufficiency].
    Salikhova NN; Akhmedzhanov RI; Mukhamadieva ShG; Sakhibov AD
    Lab Delo; 1989; (3):48-52. PubMed ID: 2469841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of blood purification on plasma levels of intact parathyroid hormone in patients with chronic renal failure.
    Liu J; Liu ZQ; Tao HQ
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):234-5. PubMed ID: 14965840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of medium-size molecules at the cell respiration level in hemodialysis patients].
    Murisasco A; Saingra S; Crevat A; Rinaudo JB; Gallice P
    J Urol Nephrol (Paris); 1979 Sep; 85(9):586-9. PubMed ID: 522203
    [No Abstract]   [Full Text] [Related]  

  • 13. [The morphological characteristics of the erythrocytes during hemosorption in patients with chronic kidney failure and suppurative intoxication].
    Samoĭlov MV; Danilkov AP; Kudriavtsev IuV; Naumov AG
    Urol Nefrol (Mosk); 1993; (1):34-7. PubMed ID: 7941124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of sisomicin during hemosorption and hemodialysis].
    Firsov AA; Treskina OS; Umnova LV; Cherniakov VL; Vetchinnikova ON
    Antibiot Med Biotekhnol; 1985 May; 30(5):352-5. PubMed ID: 4026255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of cefazolin during hemosorption and hemodialysis].
    Firsov AA; Treskina OS; Nasonov VN; Umnova LV; Cherniakov VL
    Antibiot Med Biotekhnol; 1986 Nov; 31(11):871-4. PubMed ID: 3813510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment with hemoperfusion and hemodialysis in patients with chronic uremia.
    Trznadel K; Kidawa Z; Luciak M; Madry K; Lutz W
    Mater Med Pol; 1979; 11(2):167-72. PubMed ID: 513839
    [No Abstract]   [Full Text] [Related]  

  • 17. Study of carbohydrate material isolated from ultrafiltrates in patients with chronic renal failure.
    Le Moël G; Strecker G; Troupel S; Dupuy CA; Galli A; Agneray J
    Biomed Pharmacother; 1983; 37(2):80-5. PubMed ID: 6616034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possibilities of hemosorption for increasing the effectiveness of treatment of patients with renal tuberculosis with chronic renal insufficiency].
    Strel'nikova VA; Mochalova TP
    Probl Tuberk; 1985; (9):48-50. PubMed ID: 4070221
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in blood composition during hemosorption in patients with terminal stage of chronic renal failure].
    Maksimenko VA; Belorusov OS; Panchina OI; Noskova LA; Marchenko AL
    Khirurgiia (Mosk); 1988 Apr; (4):85-8. PubMed ID: 3398423
    [No Abstract]   [Full Text] [Related]  

  • 20. [Concentration of middle-sized molecules in the blood of children with chronic renal failure during treatment with short-term hemodialysis].
    Gudim VI; Sigalla P; Ivanova VS; Oldag K
    Vopr Med Khim; 1980; 26(6):742-6. PubMed ID: 7456404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.